Primary Record
vincamine
- In stock
- 3,008 g
- Purity
- 99.1 %
- CAS
- 1617-90-9
Compound Identifiers & Properties
- CAS
- 1617-90-9
- PubChem CID
- 15376
- SMILES
- CC[C@@]12CCCN3[C@@H]1C4=C(CC3)C5=CC=CC=C5N4[C@](C2)(C(=O)OC)O
- Canonical SMILES
- CC[C@]12CCCN3CCc4c(n(c5ccccc45)[C@@](O)(C(=O)OC)C1)[C@@H]32
Names & Synonyms
- vincamine
- Pervincamine
- Arteriovinca
- Angiopac
- Devincan
- Vincafor
- Vincamidol
- Minorine
- Vincimax
- Novicet
- Oxygeron
- Vincagil
- Vincamin
- Equipur
- Anasclerol
- Vincafolina
- Tripervan
- Devinkan
- Vincadar
- Monorin
- Methyl vincaminate
- (+)-Vincamine
- 1617-90-9
- Vincasaunier
- Vincapront
- Vinkametrin
- Vincamina
- Decincan
- Minorin
- Pervone
- Perval
- Ocu-vinc
- Vinodrel retard
- Vincachron
- Vincaminum
- Vincapan
- Vinca
- Vraap
- Vinca-Ecobi
- Vinca-Minor
- Cerebroxine
- Cetal retard
- Anasclerol (base)
- Cetal
- Vincamina [DCIT]
- Vincamine base
- Pervincamine;
- Teprosilic Acid
- Vincamarine;
- Minorine;
- Vincamine CRS
- Vincamine (FP)
- Vincamine (INN)
- Prestwick_495
- Vincaminum [INN-Latin]
- Cetal retard (TN)
- Vincamine, 98%
- OXICEBRAL
- (+)-cis-Vincamine
- Vincamine (Standard)
- 996XVD0JHT
- Vincamine [INN:BAN:DCF]
- Vincamine, 98% 1g
- UNII-996XVD0JHT
- VINCAMINE [INN]
- C21H26N2O3
- DTXSID9040134
- VINCAMINE [MI]
- VINCAMINE [HSDB]
- Prestwick0_000271
- Prestwick1_000271
- Prestwick2_000271
- Prestwick3_000271
- RefChem:194264
- RXPRRQLKFXBCSJ-GIVPXCGWSA-N
- MFCD00078054
- D08UGJ
- VINCAMINE [MART.]
- HSDB 7150
- AC1L25RL
- VINCAMINE [WHO-DD]
- CHEBI:9985
- Alkaloid obtained from Vinca minor
- Vincamine [BAN:DCF:INN]
- BSPBio_000142
- DTXCID7020134
- GTPL349
- MLS002154249
- SCHEMBL147179
- EINECS 216-576-3
- SPBio_002361
- NSC 91998
- NSC-91998
- BPBio1_000158
- Vincamine, 99% - 1G 1g
- CHEMBL1165342
- SCHEMBL29710919
- VINCAMINE [EP MONOGRAPH]
- BCBcMAP01_000080
- ERK5-6H12
- HY-B1021R
- C04AX07
- Vincamine for system suitability CRS
- HMS1568H04
- HMS2095H04
- HMS2268C20
- HMS3712H04
- AMY39091
- BCP05837
- CID15376
- HY-B1021
- methyl ethyl(hydroxy)[?]carboxylate
- NSC91998
- ZINC1069082
- Tox21_111342
- Tox21_301968
- CID:15376
- s3891
- AKOS015896471
- C21-H26-N2-O3
- Tox21_111342_1
- ACN-036655
- CCG-208544
- CS-4536
- DB13374
- EBC-618387
- EBD2197880
- FV65205
- J7.533G
- KS-5179
- SMP1_000314
- Vincamine, analytical reference material
- NCGC00094824-01
- NCGC00184983-01
- NCGC00184983-03
- NCGC00255542-01
- AC-22625
- AN-49543
- BC681377
- N016
- SC-19228
- SMR000112509
- SY057985
- CAS-1617-90-9
- SID:134224874
- LS-162175
- NS00006858
- ST24050348
- 14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester
- C09251
- D08677
- Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3alpha,14beta,16alpha)-
- J10447
- 617V909
- A851579
- D014749
- F463487
- Q416225
- I06-1879
- BRD-K40902647-001-03-7
- Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methylester, (3a,14b,16a)-
- methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate
- Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3alpha,14beta,16.)
- methyl 14beta-hydroxy-14,15-dihydro-3alpha,16alpha-eburnamenine-14alpha-carboxylate
- Vincamine Working Standard (Secondary Reference Standard)
- Methyl (41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
- Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-, methyl ester, (3.alpha.,14.beta.,16.alpha.)-
- (3alpha,14S,16alpha)-14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester
- (3alpha,16alpha)-14-Hydroxy-14,15-dihydroeburnamenine-14alpha-carboxylic acid methyl ester
- Methyl 14beta-hydroxy-3alpha,16alpha-14,15-dihydroeburnamenine-14alpha-carboxylate
- (3-alpha,14-beta,16-alpha)-14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester
- (3alpha,14beta,16alpha)-14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester
- (3aS,5S,11S)-3a-Ethyl-5-hydroxy-1,2,3,3a,4,5,10,11b-octahydro-11H-5a,11a-diaza-benzo[cd]fluoranthene-5-carboxylic acid methyl ester<br/>Cerebroxine<br/>Devincan<br/>Pervincamine<br/>Vincamine<br/>Vincapront<br/>Vincimax
- (4(1)S,12S,13aS)-methyl 13a-ethyl-12-hydroxy-2,3,4(1),5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
- (41S,12S,13aS)-methyl 13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
- 216-576-3
- Eburnamenine-14-carboxylic acid, 14,15-dihydro-14-hydroxy-,methyl ester, (3alpha,14beta,16alpha)-
- methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo(9.6.2.0^(2,7).0^(8,18).0^(15,19))nonadeca-2,4,6,8(18)-tetraene-17-carboxylate
- methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo(9.6.2.02,7.08,18.015,19)nonadeca-2,4,6,8(18)-tetraene-17-carboxylate
- methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0?,?.0?,??.0??,??]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate
- methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2(7),3,5,8(18)-tetraene-17-carboxylate
- methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate
- methyl(15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate
- Methyl(41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
- Vincamine; Minorine; 1H-Indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine eburnamenine-14-carboxylic acid deriv.; (+)-Vincamine; (+)-cis-Vincamine; Angiopac; Arteriovinca; Devincan; Devinkan; Equipur; Methyl vincaminate; Minorin; NSC 91998; Novicet; Ocu-vinc; Oxygeron; Perval; Pervincamine; Pervone; Sostenil; Tripervan; Vincadar; Vincafarm; Vincafolina; Vincafor; Vincagil; Vincalen; Vincamidol; Vincamin; Vincapan; Vincapront; Vincimax; Vinodrel Retard; Vinvasaunier; Vraap; cis-Vincamine; (3alpha,14beta,16alpha)-14,15-Dihydro-14-hydroxyeburnamenine-14-carboxylic acid methyl ester